Advanced Biotechnology

Next-generation biologics.

Scaling mammalian cell culture and recombinant protein therapeutics to meet the exact demands of global healthcare providers.

Extreme close-up of an automated robotic production line handling sterile vials, cool clinical lighting with royal blue accents, crisp 35mm photography.
Extreme close-up of an automated robotic production line handling sterile vials, cool clinical lighting with royal blue accents, crisp 35mm photography.
Wide architectural shot of a futuristic biotechnology laboratory with illuminated isolation chambers, crisp high-key lighting, teal cinematic highlights.
Wide architectural shot of a futuristic biotechnology laboratory with illuminated isolation chambers, crisp high-key lighting, teal cinematic highlights.
Therapeutic Platforms

Precision at scale.

Monoclonal Antibodies

Operating advanced mammalian cell culture infrastructure for the production of biosimilar monoclonal antibodies and recombinant proteins. Our facilities maintain strict GMP compliance throughout the entire upstream and downstream process.

Viral Vector Technologies

Developing and scaling next-generation gene therapy platforms. Our specialized suites provide the controlled environments necessary for complex viral vector manufacturing and advanced cell therapy solutions.

Biologics & Gene Therapy Specifications

Product Category: Biologics & Advanced Gene Therapy Products
Dosage Forms: Sterile injectable solutions, concentrates, lyophilized powders, and viral vector formulations
Appearance: Clear, colorless to slightly opalescent solution or white lyophilized powder (product dependent)
Manufacturing Standard: Produced in GMP-compliant biopharmaceutical facilities
Quality Testing: Identity, purity, potency, sterility, endotoxin, and stability testing
Packaging: Sterile glass vials, infusion containers, or specialty packaging depending on product requirements
Storage: Store at 2°C to 8°C or as specified for individual products. Do not freeze unless indicated.
Shelf Life: Product-specific (typically 24–36 months)
Applications: Oncology, rare diseases, immunology, neurology, hematology, and genetic disorders
Documentation Available: Technical Data Sheet (TDS), Certificate of Analysis (CoA), Product Specifications, and Quality Documentation upon request.

Contact Us

Verify our capabilities.

Review technical data sheets, certificates of analysis, and facility specifications for our biosimilar monoclonal antibody programs.